These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 20889945)
1. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial. King KJ; Douglas MJ; Unger W; Wong A; King RA Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945 [TBL] [Abstract][Full Text] [Related]
2. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Borruto F; Treisser A; Comparetto C Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549 [TBL] [Abstract][Full Text] [Related]
3. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. George RB; McKeen D; Chaplin AC; McLeod L Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255 [TBL] [Abstract][Full Text] [Related]
4. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial. Adnan N; Boland F; Murphy DJ Trials; 2017 Nov; 18(1):541. PubMed ID: 29141679 [TBL] [Abstract][Full Text] [Related]
5. Ergometrine given during caesarean section and incidence of delayed postpartum haemorrhage due to uterine atony. Lourens R; Paterson-Brown S J Obstet Gynaecol; 2007 Nov; 27(8):795-7. PubMed ID: 18097896 [TBL] [Abstract][Full Text] [Related]
6. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study. Lavoie A; McCarthy RJ; Wong CA Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327 [TBL] [Abstract][Full Text] [Related]
7. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Dyer RA; Butwick AJ; Carvalho B Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725 [TBL] [Abstract][Full Text] [Related]
8. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Carvalho JC; Balki M; Kingdom J; Windrim R Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392 [TBL] [Abstract][Full Text] [Related]
9. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial. Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995 [TBL] [Abstract][Full Text] [Related]
10. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650 [TBL] [Abstract][Full Text] [Related]
12. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Rath W Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial. Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768 [TBL] [Abstract][Full Text] [Related]
14. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity. Peska E; Balki M; Maxwell C; Ye XY; Downey K; Carvalho JCA Anaesthesia; 2021 Jul; 76(7):918-923. PubMed ID: 33227150 [TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery. Hernández-Castro F; López-Serna N; Treviño-Salinas EM; Soria-López JA; Sordia-Hernández LH; Cárdenas-Estrada E Int J Gynaecol Obstet; 2016 Feb; 132(2):184-7. PubMed ID: 26534874 [TBL] [Abstract][Full Text] [Related]
16. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2. Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial. Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927 [TBL] [Abstract][Full Text] [Related]
18. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. Attilakos G; Psaroudakis D; Ash J; Buchanan R; Winter C; Donald F; Hunt LP; Draycott T BJOG; 2010 Jul; 117(8):929-36. PubMed ID: 20482535 [TBL] [Abstract][Full Text] [Related]
19. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial. Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial. Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T Trials; 2016 Mar; 17():155. PubMed ID: 27004531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]